COVID-19 and hyperglycemia/diabetes  

作　　者：Konstantinos Michalakis Ioannis Ilias 

机构地区：[1]Private Practice,Athens GR-11521,Greece [2]Department of Endocrinology,Diabetes and Metabolism,Elena Venizelou Hospital,Athens GR-11521,Greece

出　　处：《World Journal of Diabetes》2021年第5期642-650,共9页世界糖尿病杂志（英文版）（电子版）

摘　　要：In early studies regarding coronavirus disease 2019(COVID-19),type 2 diabetes mellitus was considered to contribute substantially to the disease’s inflammatory response.Subsequently,even hyperglycemia,regardless of insulin resistance or diabetes mellitus,was found to be additionally harmful.Recent studies have shown inflammation of the pancreaticβcells in COVID-19,even leading to new onset diabetes mellitus.We hereby summarize core literature on glycemia and COVID-19,and present implicated pathways and mechanisms.

关 键 词：COVID-19 Humans SARS-CoV-2 Risk factors GLUCOSE INFLAMMATION DIABETES 

分 类 号：R587.2[医药卫生—内分泌] R563.1[医药卫生—内科学]